Human immunoglobulin

This product contains broad-spectrum IgG antibodies against viruses, bacteria or other pathogens. In addition, the unique type of immunoglobulin and unique type antibodies can form a complex immune network, so it has the dual therapeutic effects of immune replacement and immune regulation. After intravenous infusion, it can quickly increase the IgG level in the recipient's blood and enhance the body's anti-infection ability and immune regulation function.

Main ingredients: Human immunoglobulin

This product is a colorless or yellow clear liquid with opalescence

1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.

Usage: Intravenous drip or dilute 1 to 2 times with 5% glucose solution for intravenous drip. The initial drip rate is 1.0 ml/min (about 20 drops/min). If there is no adverse reaction after 15 minutes, the rate can be gradually increased. The fastest drip rate should not exceed 3.0 ml/min (about 60 drops/min). Dosage: Follow the doctor's advice. Recommended dose: 1 Primary immunoglobulin deficiency or hypoimmunoglobulinemia: First dose: 400 mg/kg body weight; Maintenance dose: 200-400 mg/kg body weight. The dosing interval depends on the patient's serum IgG level and condition, generally once a month. 2 Primary thrombocytopenic purpura: 400 mg/kg body weight per day for 5 consecutive days. Maintenance

Generally, there are no adverse reactions. Very few patients experience transient headaches, palpitations, nausea and other adverse reactions during infusion, which may be related to the rapid infusion speed or individual differences. Most of the above reactions are mild and often occur within one hour after the start of infusion. Therefore, it is recommended to regularly observe the patient's general condition and vital signs during the entire infusion process, slow down or pause the infusion when necessary, and generally recover on their own without special treatment. Some patients may experience the above reactions after the end of the infusion, and generally recover on their own within 24 hours.

1. Those who are allergic to human immunoglobulin or have other severe allergic history. 2. Those with selective IgA deficiency with anti-IgA antibodies.

This product should be infused alone and should not be mixed with other drugs.

Store and transport at 2-8℃ away from light. Valid for 30 months

150mg (10%, 1.5ml)/bottle

Shenzhen Weiguang Biological Products Co., Ltd.

• Founded in:

  1986-04-07

• Address:

  First Floor, Office Building, No. 3402, Guangqiao Avenue, Biyan Community, Guangming Street, Guangming District, Shenzhen

• Tax NO.:

  91440300192471818P

• Registered Funds:

  226.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view